down arrow

Dipna Pharmachem

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE0MC401013
  • NSEID:
  • BSEID: 543594
INR
15.31
-0.59 (-3.71%)
BSENSE

Apr 11, 12:40 PM

BSE+NSE Vol: 3000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Standalone - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 64.46% vs 37.35% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 46.33% vs 7.69% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 108.73% vs 57.89% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 19.02% vs -21.85% in Mar 2023

Compare Profit and Loss Results of Dipna Pharmachem
Markets Mojo
Figures in Rs cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
164.00
9,264.00
-9,100.00
-98.23%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
164.00
9,264.00
-9,100.00
-98.23%
Expenditure (Ex Depriciation)
Stock Adjustments
-18.00
-25.00
7.00
28.00%
Raw Materials Consumed
176.00
2,933.00
-2,757.00
-94.00%
Power & Fuel Cost
0.00
70.00
-70.00
-100.00%
Employee Cost
0.00
1,982.00
-1,982.00
-100.00%
Operating Expenses
0.00
143.00
-143.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
806.00
-805.00
-99.88%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
136.00
-136.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
160.00
6,939.00
-6,779.00
-97.69%
Operating Profit (PBDIT) excl Other Income
3.00
2,325.00
-2,322.00
-99.87%
Other Income
0.00
266.00
-266.00
-100.00%
Operating Profit (PBDIT)
3.00
2,592.00
-2,589.00
-99.88%
Interest
1.00
15.00
-14.00
-93.33%
Profit before Depriciation and Tax
1.00
2,577.00
-2,576.00
-99.96%
Depreciation
0.00
317.00
-317.00
-100.00%
Profit Before Taxation & Exceptional Items
1.00
2,259.00
-2,258.00
-99.96%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
1.00
2,259.00
-2,258.00
-99.96%
Provision for Tax
0.00
436.00
-436.00
-100.00%
Profit After Tax
1.00
1,823.00
-1,822.00
-99.95%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1.00
7,868.00
-7,867.00
-99.99%
Profit Available for appropriations
2.00
9,691.00
-9,689.00
-99.98%
Appropriations
2.00
9,691.00
-9,689.00
-99.98%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.9
45.52
-44.62
-98.02%
Profit And Loss - Net Sales
Net Sales 164.34 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 64.46% vs 37.35% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.43 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 46.33% vs 7.69% in Mar 2023

Profit And Loss - Interest
Interest 2.00 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 108.73% vs 57.89% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 1.09 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 19.02% vs -21.85% in Mar 2023